Quantcast
Last updated on April 19, 2014 at 18:42 EDT

Latest Pamlab L.L.C. Stories

2013-01-28 08:28:50

NEW ORLEANS, Jan. 28, 2013 /PRNewswire/ -- Pamlab L.L.C., developer and marketer of Metanx(®), announced today that a multicenter study, done in collaboration with Tulane University, was published in The American Journal of Medicine. The study suggests that nutritional management of diabetic peripheral neuropathy (DPN) with L-methylfolate, methylcobalamin, and pyridoxal 5'-phosphate, a prescription medical food dispensed by prescription and commercially known as Metanx(®), improves...

2012-11-19 08:28:32

NEW ORLEANS, Nov. 19, 2012 /PRNewswire/ -- PamLab L.L.C., developer and marketer of Metanx(®), announced today that a study published in The American Journal of Pharmacy Benefits demonstrates the effects of Metanx(®) on commercially insured patients with Diabetic Peripheral Neuropathy (DPN). Patients in the Metanx(®) group had lower risks of hospitalization and a reduction of disease related costs. The retrospective study, conducted by Rolin Wade RPh, MS from Cerner Research in...